Caxton Associates LP Homology Medicines, Inc. Transaction History

Caxton Associates LP

  • $1.78 Billion
  • Q1 2024

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2022

Aug 15, 2022
SELL
$1.39 - $3.12 $244,417 - $548,620
-175,840 Closed
0 $0
Q1 2022

May 16, 2022
BUY
$2.6 - $4.17 $345,235 - $553,705
132,783 Added 308.39%
175,840 $535,000
Q4 2021

Feb 14, 2022
BUY
$3.64 - $7.78 $108,985 - $232,940
29,941 Added 228.28%
43,057 $157,000
Q3 2021

Nov 15, 2021
BUY
$6.01 - $8.71 $78,827 - $114,240
13,116 New
13,116 $103,000

Others Institutions Holding FIXX

# of Institutions
5
Shares Held
66.2K
Call Options Held
0
Put Options Held
0
View Full List

About Homology Medicines, Inc.

FIXX Quotes by TradingView
  • Ticker FIXX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 57,402,000
  • Description
  • Homology Medicines, Inc., a genetic medicines company, focuses on transforming the lives of patients suffering from rare genetic diseases. Its proprietary platform is designed to utilize its human hematopoietic stem cell derived adeno-associated virus vectors (AAVHSCs) to deliver genetic medicines in vivo either through a gene therapy or nucleas...
More about FIXX
Track This Portfolio

Track Caxton Associates LP Portfolio

Follow Caxton Associates LP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Caxton Associates LP, based on Form 13F filings with the SEC.

News

Stay updated on Caxton Associates LP with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email